Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ENTACAPONE 200 MG TABLET

ENTACAPONE
$0.3628per EA

Strength

200 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332047831

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ENTACAPONE

Approval Type

Generic (ANDA)

FDA Application

ANDA212601

On Market Since

1/6/2022

Pharmacological Classes

Catechol O-Methyltransferase Inhibitors
Catechol-O-Methyltransferase Inhibitor

Price History

1W

0.0%

1M

+0.7%

3M

+2.8%

6M

+13.7%

1Y

-2.8%

3Y

-8.9%

5Y

N/A

All

-15.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ENTACAPONE 200 MG TABLET
Generic
00527183037•Lannett Company Inc.
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
00781557801•Sandoz Inc.
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
00904682207•Major Pharmaceuticals
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
27241004910•Ajanta Pharma USA Inc.
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
33342026011•Macleods Pharmaceuticals Limited
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
50268029515•AvPAK
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
60687018821•American Health Packaging
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
65862065401•Aurobindo Pharma Limited
$0.3628
per EA
ENTACAPONE 200 MG TABLET
Generic
47335000788•Sun Pharmaceutical Industries Inc.
$0.4113
per EA
CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB
Generic
00781563701•Sandoz Inc.
$0.6289
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy